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Objective: Our objective was to assess the sympathoadrenal response in 
pediatric patients undergoing repair of congenital cardiac defects. Methods: 
Plasma catecholamine (norepinephrine and epinephrine) and neuropep- 
tide Y concentrations were quantified before and after cardiopulmonary 
bypass to assess the response to cardiopulmonary bypass. To determine the 
response to aortic occlusion, levels of plasma catecholamines and neu- 
ropeptide Y were measured at the time of and immediately after release of 
the aortic crossclamp. Results: During cardiopulmonary bypass; no signif- 
icant change in levels of plasma norepinephrine (n = 43), epinephrine (n = 
37), or neuropeptide Y (n = 46) was observed. Aortic occlusion induced a 
significant increase in plasma neuropeptide Y, but not in catecholamines. 
There was a greater increase in plasma neuropeptide Y in children older 
than age 1 year than in those younger than 1 year. Conclusions: Plasma 
neuropeptide Y may be a useful marker of sympathetic nervous system 
activity. Children younger than age 1 year showed a lesser sympathetic 
response compared with the response in older children. (J Thorac Cardio- 
vasc Surg 1997;113:278-84) 
T he response of the sympathetic nervous ystem to operation and cardiopulmonary b pass (CPB) 
has been extensively studied in adults. I' 2 Anand and 
Hickey 3and Anand, Hansen, and Hickey 4have also 
examined this response in neonates undergoing 
cardiac operations for repair of congenital cardiac 
defects. In all studies to date the "sympathoadrenat 
stress response" has been assessed by changes in 
plasma Catecholamine levels. Plasma cat- 
echolamines, particularly plasma norepinephrine, 
used as a "window" to examine the activation of the 
sympathetic nervous ystem may not be a sufficiently 
sensitive marker because plasma norepinephrine 
represents only a fraction of the actual amount 
released from sympathetic nerve terminals, most of 
which is either recaptured or metabolized. 5 The 
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sensitivity and accuracy of plasma norepinephrine 
used as a measure of the activity of the immature 
sympathetic nervous system are even less certain. 
The highest plasma norepinephrine concentrations, 
unrelated to catecholamine-secreting tumors, have 
been reported in the human neonate. In neonates 
undergoing cardiac operation, very high concentra- 
tions of plasma norepinephrine and epinephrine 
have been documented preoperatively?' 4 Because 
the cardiovascular sympathetic neuroeffector system 
continues to mature in the postnatal period, age- 
related changes in the sympathoadrenal stress re- 
sponse might also occur? Thus, in neonates, the 
high circulating catecholamine l vels might be a 
result of incomplete development of the reuptake 
mechanism for norepinephrine or immaturity of 
enzyme systems that metabolize catecholamines, or 
both these reasons, or a result of an enhanced 
activation of the sympathetic nervous ystem. 
Plasma neuropeptide Y (NPY), a 36 amino acid 
peptide, has often been used as noncatecholamine 
marker for sympathetic neural activity. NPY was 
first isolated in 1982 and is abundant in the cardio- 
vascular system, where it colocalizes with norepi- 
nephrine in the sympathetic nerve endings. 7 During 
intense sympathetic neural stimulation, NPY is 
coreleased with norepinephrine and functions both 
directly as a neuromediator and indirectly as a 
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neuromodulator,  s Both plasma catecholamine and 
NPY concentrations are elevated with activation of 
the sympathetic nervous system in human sub- 
jects.9, 10 In adult patients undergoing cardiac op- 
eration, aortic occlusion elicits increases both in 
catecholamines and NPY as part of the metabolic- 
hormonal  stress response, z There is no reuptake of 
NPY  released from nerve endings. It is metabolized 
solely by plasma peptidases. Its plasma half-life is 
between 20 and 30 minutes, which is much longer 
than that of plasma catecholamines with a half-life 
of about 2 minutes. ~1 
We examined the effect of CPB and aortic occlu- 
sion on plasma catecholamines and NPY in children 
of various ages to determine whether there are 
age-related changes in the sympathoadrenal stress 
response. Furthermore, we compared the changes in 
plasma catecholamine concentrations with those of 
plasma NPY  to determine whether plasma NPY 
may be a useful marker of sympathetic nervous 
system activity in the pediatric patient. 
Methods 
After approval from the Institutional Review Board for 
human studies, we obtained written, informed consent 
from parents of patients enrolled in the study. All subjects 
were undergoing elective cardiac operation at the Babies 
and Children's Hospital done by a single pediatric ardio- 
thoracic surgeon (J. M. Q.) during the period from 
December 1991 to June 1994. All patients underwent 
nonpulsatile hypothermic CPB. 
Anesthesia was induced with fentanyl, 25/~g/kg, and the 
lungs were ventilated with 100% O 2. Vecuronium was 
used for muscle relaxation. A total dose of fentanyl of 100 
/~g/kg was administered to all patients before initiation of 
CPB. Fentanyl was administered by intravenous bolus 
injections between the time of sternotomy and initiation 
of CPB. At the discretion of the attending anesthesiolo- 
gist, isoflurane or halothane was used to supplement 
anesthesia, s needed, before CPB. Nitroprusside infusion 
at a dose of 1 to 4 /~g/kg was administered to facilitate 
cooling and rewarming to the predetermined core tem- 
perature as requested by the surgeon. Additional vecuro- 
nium and a dose of 0.15 mg/kg of midazolam were given at 
rewarming. The total dose of fentanyl (on a per kilogram 
of body weight basis) was the same for all patients at each 
of the sampling points indicated later in this section. The 
choice and doses of inotropic agents administered on 
separation from CPB and during the postoperative p riod 
were at the discretion of the attending anesthesiologist. 
Patients were excluded from the study if they were 
receiving an inotropic agent before the operation. 
Four samples of blood were obtained from all patients 
as follows: (1) after induction of anesthesia with a 25 
/~g/kg dose of fentanyl, when hemodynamic parameters 
were stable for at least 10 minutes, and before surgical 
incision (pre-CPB); (2) during hypothermic bypass and 





Total CPB time (min) 
Aortic crossclamp time 
(min) 
Lowest emperature 
during CPB (° C) 
Median 11.5 (range 1 day-211 mo) 
10.7 _+ 8.8 (range 2.4-40) 
30 male/16 female 
102.8 _+ 47.5 (95% CI 88.7-116.9) 
54.0 _+ 27.0 (95% CI 46.0-62.0) 
24.8 -+ 0.7 (range 18-32) 
Data are expressed asmeans plus or minus tandard deviation, unless 
otherwise specified. 
within 1 minute after the application of the aortic cross- 
clamp (pre-AO); (3) during bypass and rewarming, within 
1 minute after removal of the aortic crossclamp (post- 
AO); and (4) at the conclusion of CPB, when the patient 
was normothermic (post-CPB). 
Blood samples were collected from an indwelling arte- 
rial catheter (time points 1 and 4) or directly from the 
CPB machine (time points 2 and 3) into prechilled tubes 
containing aprotinin and ethylenediaminetetraacetic acid.
They were centrifuged at 4 ° C and the separated plasma 
was stored at -70°C until assayed for NPY and cat- 
echolamines. Plasma NPY was measured with use of a 
radioimmunoassay kit (Peninsula Laboratories). The sen- 
sitivity of the radioimmunoassay was 2 pg/ml. Plasma 
epinephrine and norepinephrine concentrations were de- 
termined by high-performance liquid chromatography. 
The sensitivity of the assay was 50 pg/ml. The interassay 
variability was 5%, with a range from 1.5% to 6.5%. 
Average recovery was 80.8% _+ 7% (mean plus or minus 
standard eviation) for norepinephrine and 83.9% +_ 3% 
(mean plus or minus standard eviation) for epinephrine. 
Data analysis. A total of 43 samples were available for 
plasma norepinephrine analysis and 37 for epinephrine 
analysis. Analysis of variance by repeated measures was 
done to assess intraoperative changes in plasma NPY and 
catecholamine l vels. Differences between pre-CPB and 
post-CPB levels were analyzed by post hoc testing with 
Scheffe's test between points 1 and 4. Changes during 
aortic occlusion were assessed by Scheffe's test between 
points 2 and 3. Regression analysis and curve fitting 
between prebypass plasma NPY or catecholamine con- 
centrations as a function of age were done to determine 
whether there were age-dependent changes. 12 Plasma 
NPY and catecholamine level differences between the two 
age groups were analyzed by unpaired t test for single time 
points and by factorial analysis of variance for multiple time 
points. 12 Unpaired t test was used to compare plasma NPY 
concentrations in patients with and without cyanotic lesions. 
To examine the interaction between age, pre-CPB NPY 
levels, pre-AO NPY levels, and the relative change in NPY 
concentration during aortic occlusion, we performed multi- 
ple regression analysis and analysis of covariance using 
changes in plasma NPY concentration during aortic occlu- 
sion as the dependent variable and age, pre-CPB NPY level, 
and pre-AO NPY level as independent variables. 12 Multiple 
regression analysis was also used to examine the interaction 
between age and temperature with changes in NPY concen- 
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Fig. 1. Age-dependent changes in level of plasma NPY pre-CPB (r = +0.505, 95% CI +0.31, +0.89, p = 
0.0028, n = 46). 
Table II. Patient characteristics for the two age groups 






3.8 _+ 3.7 (range 1 day-t1 mo) 
4.9 _+ 2.5 (range 2.4-12.2) 
15 male/8 female 
Digoxin and furosemide/diuretics (8);prostaglandin E 1 (6) 
Ventricular septal defect (3) 
Atrioventricular canal (4) 
Tetralogy of Fallot (3) 
Hypoplastic left heart syndrome (1) 
Transposition of great vessels (4) 
Truncus arteriosus (3) 
Total/partial anomalous pulmonary venous return (2) 
Single ventricle (2) 
Pulmonary-aortic window (1) 
60 -+ 53.4 (range 12-211 mo)* 
16.6 _+ 9.0 (range 5.2-40)* 
15 male/8 female 
Digoxin and furosemide/diuretics (8) 
Ventricular septal defect (4) 
Atrioventricular canal (3) 
Tetralogy of Fallot (6) 
Atrial septal defect (2) 
Transposition of great vessels (2) 
Mitral valve disease (1) 
Aortic valve disease (4) 
Single ventricle (1) 
Numbers in parentheses refer to number of patients. Data are expressed as means plus orminus standard deviation, unless otherwise sp cified. 
*p < 0.05 compared with <l-year-old patients. 
Table I I I .  Intraoperative events for the two age groups 
<1 yr (n = 23) >1 yr (n = 23) 
Total CPB time (min) 104.6 -+ 37.3 (95% CI 88.4-120.7) 101.1 _+ 56.8 (95% CI 76.5-125.6) 
Aortic crossclamp time (rain) 53.8 + 23.1 (95% CI 43.9-63.8) 54.2 _+ 31.0 (95% CI 40.8-67.6) 
Lowest temperature during CPB (°C) 22.96 + 5.4 (range 18-32) 26.6 _+ 3.3 (range 24-32)* 
No. of patients receiving inhaled agents 4 9 
Data are xpressed asmeans plus or minus standard deviation, unless otherwise pecified. 
*p < 0.05 compared with <l-year-old patients. 
tration during aortic occlusion. All appropriate data are 
expressed as means plus or minus the standard error of the 
mean. A value o fp  < 0.05 was deemed significant. 
Results 
Patient characteristics and intraoperative vents. 
Pat ient  character ist ics and in t raoperat ive  course are 
summar ized  in Tab le  I. 
Patient age and plasma catecholamine and NPY 
concentrations. Pre-CPB plasma NPY level was 
significantly correlated with age (r = +0.505, 95% 
confidence interval [CI] +0.31, +0.89,p = 0.0028). 
With increasing age, there was a gradual decline in 
level of plasma NPY, with the sharpest decline 
taking place during the first year (Fig. 1). No such 
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correlation was found with either plasma epineph- 
rine or norepinephrine (data not shown). 
Plasma catecholamine and NPY levels during 
CPB and aortic occlusion. Plasma catecholamine 
levels were extremely variable among the pediatric 
patients undergoing cardiac operations. There was 
no significant change in plasma norepinephrine, 
epinephrine (Fig. 2, A), or NPY (Fig. 2, B) concen- 
trations after CPB compared with before CPB. In 
response to aortic occlusion, plasma catecholamine 
concentrations remained unchanged, but there was a 
significant increase in plasma NPY (Fig. 2, A and B). 
Catecholamine and NPY levels in two different 
age groups. Because the decline in pre-CPB plasma 
NPY concentrations was greatest in patients oper- 
ated on during their first year of life, patients were 
divided into two groups: those younger and those 
older than age 1 year. Summaries of patient charac- 
teristics and intraoperative events for the two age 
groups are presented in Tables II and HI. There 
were no significant differences between the two 
groups except for age and the lowest temperature 
attained uring CPB. The total dose of fentanyl was 
the same at each sampling point, on a per kilogram 
of weight basis. Only a minor proportion of each 
group received supplemental inhaled agents. 
In each age group, changes in plasma catechol- 
amine (Fig. 3, A) and NPY (Fig. 3, B) concentra- 
tions during CPB and aortic occlusion were ex- 
pressed as percent change from pre-CPB and 
pre-AO values, respectively. Though children older 
than age 1 year appeared to have larger increases in 
norepinephrine and epinephrine levels during CPB 
and aortic occlusion (Fig. 3, A), there was no 
statistically significant increase in either age group 
because of the large interpatient variability. Simi- 
larly, there was no significant increase in plasma 
NPY concentration during CPB in either age group. 
In contrast, plasma NPY levels increased signifi- 
cantly during aortic occlusion (p = 0.0005), and 
values in the older age group increased significantly 
more (p = 0.0003) than those in the younger group 
(p = 0.035) (Fig. 3, B). Multiple regression analysis 
revealed that the age-dependent plasma NPY re- 
sponse could not be accounted for by the fact that 
the younger children had much higher pre-CPB (r = 
+0.001, p = 0.667) and pre-AO (r = -0.002, p = 
0.201) plasma NPY concentrations. 
Effect of cyanosis and temperature on changes in 
plasma NPY levels during aortic occlusion. We 
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Fig. 2. Data are expressed as means plus or minus the 
standard error of the mean. A, Changes in plasma 
concentrations of norepinephrine (NE) (n = 43) and 
epinephrine (EPI) (n = 37) during CPB and aortic 
occlusion (140): pre-CPB, norepinephrine 7.5 _+ 1.6 
pmol/ml; pre-CPB, epinephrine 1.4 _+ 0.6 pmol/ml; 
pre-AO, norepinephrine 8.2 + 1.4 pmol/ml; pre-AO, 
epinephrine 4.8 _+ 1.2 pmol/ml. B, Changes in plasma 
NPY concentrations during CPB and aortic occlusion. 
Plasma NPY level did not change from pre-CPB to 
post-CPB measurement, but increased significantly 
from pre-AO to post-AO measurement: pre-CPB, NPY 
136.3 _+ 1.6.1 pg/ml; pre-AO, NPY 153.3 _+ 19.3 pg/ml. 
*p < 0.05 post-AO versus pre-AO. 
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Fig. 3. Data are expressed as means plus or minus the standard error of the mean. Relative changes in 
levels of plasma catecholamines and NPY during CPB and aortic occlustion (AO) for children older (n = 
23) and younger (n = 23) than age 1 year are depicted. Data are expressed as percent change (A) from 
values before CPB or before aortic occlusion. A; Changes in levels of plasma norepinephrine (NE) and 
epinephrine (Epi) in the two groups during CPB and aortic occlusion did not differ significantly: ounger 
than 1 year, pre-AO norepinephrine 8.8 _+ i.9 pmol/ml (n = 22); pre-AO epinephrine 1.9 + 0.7 pmol/ml 
(n = 19); pre-CPB norepinephrine 8.5 +_ 2.0 pmol/ml (n = 22); pre-CPB epinephrine 0.9 ± 0.3 pmol/ml 
(n = 19) and older than i year, pre-AO norepinephrine 7.5 + 2.2 pmol/ml (n = 21); pre-AO epinephrine 
7.7 ± 2.0 pmol/ml (n = 18); pre-CPB norepinephrine 6.4 ± 2.5 pmol/ml (n = 21); pre-CPB epinephrine 
1.9 - 0.3 pmol!ml (n = 18). B, Changes in plasma NPY concentration i  children older (n = 23) and 
younger (n = 23) than age 1 year during CPB and aortic occlusion. Plasma NPY concentration significantly 
increased uring aortic occlusion, but not CPB, in both age groups. The older than age i year group had 
a significantly greater increase in plasma NPY level than the younger group: younger than 1 year, pre-CPB 
NPY 194.3 -+ 23.0 pg/ml; pre-AO NPY 227.6 ± 29. 5 pg/ml and older than 1 year, pre-CPB NPY 72.7 + 
11.8 pg/ml; pre-AO NPY 78.9 ± 12.3 pg/ml. *p < 0.05 versus younger than age 1 year. 
lesions or the degre of hypothermia might have 
contributed to the differences in plasma NPY re- 
sponse during aortic occlusion in the two groups. 
There was no significant difference in pre-CPB 
plasma NPY concentrations between children with 
cyanotic and acyanotic lesions. The presence of 
cyanotic lesions also did not have any effect on the 
magnitude of change in plasma NPY concentrations 
during aortic occlusion (data not shown). Though 
younger patients were cooled to lower core temper- 
atures during CPB than older children, the relative 
change in plasma NPY concentration was not corre- 
lated with the nadir of hypothermic temperature (r = 
+0.173, 95% CI -0.12, +0.47, p -- 0.25) (Fig. 4). 
Discuss ion  
The main findings of this study were that resting 
plasma NPY concentrations measured before CPB 
declined with increased age and that change in NPY 
concentrations can be used in pediatric patients to 
assess the response of the sympathetic nervous 
system. Although levels of both plasma cat- 
echolamines and NPY have been documented to 
decline in an age-dependent fashion in healthy 
children,13, 14 in children with congenital cardiac 
defects in the present study an age-dependent de- 
cline was only observed for pre-CPB plasma NPY 
levels, but not for plasma catecholamine levels. The 
heterogeneity of diagnoses among patients probably 
contributed to the large variability in levels of both 
plasma catecholamines and NPY. The higher 
plasma concentrations of catecholamines in the very 
young might be the result of immaturity in catechol- 
amine metabolism or uptake, or both, leading to a 
greater amount of "spillover" into the plasma even 
though there may be reduced synthesis or release, 
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whereas the higher plasma NPY levels in younger 
children may be a result of maturational differences 
in the amount or activity of plasma peptidases that 
metabolize NPY. 
There is indirect evidence that the ontogeny of 
the human cardiovascular sympathetic nervous ys- 
tem, similar to that in other mammalian species, 15-17 
is not fully established until well into the postnatal 
period. 18-21 Human neonates, however, can mount a 
sympathetic :response, as evidenced by substantial 
increases in plasma norepinephrine and epinephrine 
levels during CPB in children anesthetized with 
morphine and halothane, 3 as was the case with 
adults undergoing CPB who received halothane, 
morphine, and fentanyl. 1 The stress response, how- 
ever, is highly dependent on the depth of anesthesia. 
Interestingly, "deep" anesthesia with high doses of 
sufentanil, which have been found to consistently 
blunt the sympathetic response during bypass in the 
adult population, also abolished the increases in 
catecholamine levels in neonates) Our data show 
that high doses of fentanyl were also able to blunt 
the increases in plasma catecholamine levels during 
aortic occlusion, although significant increases in 
levels of plasma NPY were still evident in all age 
groups. This is consistent with the idea that even 
very young children can generate a sympathetic 
response, but the response was only detectable by 
changes in plasma NPY and not plasma cat- 
echolamines. 
An elevation in plasma catecholamine and NPY 
concentrations has been consistently observed in 
patients with increased activation of the sympathetic 
nervous system. 9 Increased plasma concentrations 
of catecholamines and NPY have been observed 
during intense sympathetic stimulation, such as aor- 
tic occlusion during CPB. 2 As in adult patients 
undergoing cardiac operation, plasma catechol- 
amine levels did not change significantly during CPB 
in our pediatric population. In contrast o adults 
receiving high-dose fentanyl anesthesia who showed 
an increase in levels of both plasma norepinephrine 
and NPY after release of aortic occlusion, 2 our 
patients only showed an increase in plasma NPY 
level. When patients were divided into two age 
groups, plasma NPY levels increased significantly 
more in the older compared with the younger chil- 
dren. This could not be attributed to the fact that 
the two groups of children were cooled to different 
hypothermic temperatures, because we were unable 
to demonstrate any relationship between the nadir 
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Fig. 4. Correlation between change (A) in plasma NPY 
concentration during aortic occlusion and the nadir of 
hypothermic temperatures (r = +0.173, 95% CI -0.12, 
+0.47,p = 0.25). 
NPY concentration during aortic occlusion. If the 
change in plasma NPY concentration during aortic 
occlusion can be thought of as a rough measure of 
NPY spillover from the heart, then there was more 
myocardial release of NPY in older children than in 
younger ones. It is possible that this was because of 
a greater sympathetic response in the more mature 
myocardium. Alternatively, the age-related iffer- 
ences in sympathetic response to aortic occlusion 
might be a result of the preexistent s ate of sympa- 
thetic nervous ystem activation. There was a signif- 
icant age-dependent decrease in pre-CPB and 
pre-AO levels of plasma NPY. However, our regres- 
sion analysis failed to demonstrate any interaction 
between age and pre-CPB or pre-AO plasma NPY 
concentration with respect o the relative change in 
plasma NPY concentration during aortic occlusion. 
Nevertheless, the capacity of the sympathetic ner- 
vous system to further espond might be limited in 
the younger children either as result of the imma- 
turity of the system or its preexisting sympathetic 
activation. That the pattern of age-dependent de- 
cline in plasma NPY concentration was preserved in
pediatric patients undergoing cardiac operation, de- 
spite the large variability among patients, and that 
changes in plasma NPY concentration could be 
detected in response to aortic occlusion suggest that 
perhaps plasma NPY may be a more useful marker 
284 Sun et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
February 1997 
of sympathetic nervous system activation in the 
pediatric patient population. 
In conclusion, our data demonstrated that pa- 
tients with congenital cardiac defects have elevated 
concentrations of pre-CPB plasma catecholamines 
at all ages, whereas the pre-CPB plasma NPY 
concentration i  these patients declined in an age- 
dependent manner. In response to CPB or aortic 
occlusion there was no change in plasma catechol- 
amine levels, but an increase in plasma NPY level 
was observed in response to aortic occlusion. The 
NPY response to aortic occlusion was greater in the 
older than the younger than 1-year-old age group, 
which may be because the age-dependent pattern of 
pre-CPB plasma NPY level permitted a greater 
margin from which to detect an increase in plasma 
NPY level after intense stimulation with aortic 
occlusion. Thus our results suggest hat (1) there 
may be an age-dependent difference in sympathetic 
response and (2) plasma NPY may be a useful 
marker for the assessment of the response of the 
sympathetic nervous ystem in the pediatric patient 
undergoing cardiac operation. 
We would like to thank Dr. Amy Jonassen, Dr. 
Jonathan Lesser, and all of the residents and perfusionists 
who participated in the collection of samples for the study. 
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